| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.49 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |